EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proton stereotactic body radiotherapy for early‐stage non‐small cell lung cancer: Influence of case‐specific characteristics on dosimetric robustness

Akihiro Yamano iD, Tatsuya Inoue iD, Ryosuke Shirata, Masashi Yamanaka, Takayuki Yagihashi iD, Takahiro Shimo iD, Yutaro Mori, Yumiko Minagawa, Koichi Tokuuye, Weishan Chang iD

Journal of Applied Clinical Medical Physics · 2026

DOI: 10.1002/acm2.70453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Akihiro Yamano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiosurgery, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI Grant-in-Aid for Young Scientists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Proton stereotactic body radiotherapy (SBRT) offers superior dose conformity. However, its clinical application remains limited due to uncertainties from setup errors and respiratory motion. This study quantified the dosimetric robustness of proton SBRT for early‐stage non‐small cell lung cancer under combined setup and interplay uncertainties and investigated the association between dosimetric robustness and case‐specific characteristics.

Methods

Robust proton SBRT plans were generated considering setup and range uncertainties. Dosimetric robustness was evaluated by comparing the clinical target volume (CTV) coverage indices (V95%, V98%, and V100%) between the nominal condition and conditions incorporating combined setup and interplay uncertainties. The influence of respiratory amplitude, tumor volume, and mean tumor CT value on dosimetric robustness was assessed.

Results

CTV coverage remained stable under nominal conditions. However, dose degradation occurred under combined setup and interplay uncertainties, with the median CTV V100% decreased below 70%. Larger respiratory amplitudes and lower mean tumor CT values were associated with reduced dosimetric robustness.

Conclusions

Combined uncertainties significantly affected the dosimetric robustness of proton SBRT depending on case‐specific characteristics. Our exploratory analysis indicates the potential need for individualized robustness strategies in proton SBRT planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiosurgeryRadiotherapy Planning, Computer-AssistedProton TherapyHumansRadiotherapy DosageOrgans at RiskRadiotherapy, Intensity-ModulatedRadiometry

Stichwörter der Autor:innen

Early‐stage non‐small cell lung cancerdosimetric robustnessinterplay effectproton stereotactic body radiotherapyrobust optimizationsetup uncertainties

Autor:innen und Institutionen

  • Department of Medical Physics, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan.
  • Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo, Tokyo, Japan.
  • Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Department of Radiation Oncology, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan.
  • Graduate School of Human Health Sciences, Tokyo Metropolitan University, Arakawa, Tokyo, Japan.

ORCID-Profile: Akihiro Yamano, Tatsuya Inoue, Takayuki Yagihashi, Takahiro Shimo, Weishan Chang

Förderung

  • JSPS KAKENHI Grant-in-Aid for Young Scientists

Zitieren

APA

Yamano, A., Inoue, T., Shirata, R., Yamanaka, M., Yagihashi, T., Shimo, T., Mori, Y., Minagawa, Y., Tokuuye, K., & Chang, W. (2026). Proton stereotactic body radiotherapy for early‐stage non‐small cell lung cancer: Influence of case‐specific characteristics on dosimetric robustness. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70453

Vancouver

Yamano A, Inoue T, Shirata R, Yamanaka M, Yagihashi T, Shimo T, et al. Proton stereotactic body radiotherapy for early‐stage non‐small cell lung cancer: Influence of case‐specific characteristics on dosimetric robustness. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70453

BibTeX
@article{Yamano2026,
  author = {Yamano, Akihiro and Inoue, Tatsuya and Shirata, Ryosuke and Yamanaka, Masashi and Yagihashi, Takayuki and Shimo, Takahiro and Mori, Yutaro and Minagawa, Yumiko and Tokuuye, Koichi and Chang, Weishan},
  title = {Proton stereotactic body radiotherapy for early‐stage non‐small cell lung cancer: Influence of case‐specific characteristics on dosimetric robustness},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  doi = {10.1002/acm2.70453}
}
Kostenlos starten →